Company · CIK 1689375

# Entrada Therapeutics, Inc.

| CIK | [1689375](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001689375) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | TRDA (Nasdaq) |
| First annual or quarterly report | 2021-12-09 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-291306 | Shelf Effective | 2025-11-06 | 2025-12-03 | 2 |
| 333-268099 | Shelf Effective | 2022-11-01 | 2024-06-24 | 4 |
| 333-260160 | IPO Final prospectus | 2021-10-08 | 2021-11-01 | 4 |

## Filings

 11

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1689375/999999999525003504/9999999995-25-003504-index.htm) Declared effective | 333-291306 | 9999999995-25-003504 |
| 2025-11-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1689375/000110465925107397/0001104659-25-107397-index.htm) Shelf registered | 333-291306 | 0001104659-25-107397 |
| 2024-06-24 | [424B5](https://www.sec.gov/Archives/edgar/data/1689375/000110465924074127/0001104659-24-074127-index.htm) Shelf takedown | 333-268099 | 0001104659-24-074127 |
| 2023-09-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1689375/000110465923105348/0001104659-23-105348-index.htm) Shelf takedown | 333-268099 | 0001104659-23-105348 |
| 2022-11-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1689375/999999999522003222/9999999995-22-003222-index.htm) Declared effective | 333-268099 | 9999999995-22-003222 |
| 2022-11-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1689375/000110465922113535/0001104659-22-113535-index.htm) Shelf registered | 333-268099 | 0001104659-22-113535 |
| 2021-11-01 | [424B4](https://www.sec.gov/Archives/edgar/data/1689375/000110465921132334/0001104659-21-132334-index.htm) Final prospectus | 333-260160 | 0001104659-21-132334 |
| 2021-10-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1689375/999999999521004082/9999999995-21-004082-index.htm) Declared effective | 333-260160 | 9999999995-21-004082 |
| 2021-10-25 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1689375/000110465921129181/0001104659-21-129181-index.htm) Amendment | 333-260160 | 0001104659-21-129181 |
| 2021-10-08 | [S-1](https://www.sec.gov/Archives/edgar/data/1689375/000110465921124689/0001104659-21-124689-index.htm) Registration filed | 333-260160 | 0001104659-21-124689 |
| 2021-08-06 | [DRS](https://www.sec.gov/Archives/edgar/data/1689375/000110465921101417/0001104659-21-101417-index.htm) Draft made public | 377-05320 | 0001104659-21-101417 |

[All filings of this company](https://equitycapital.markets/filings?cik=1689375) · [CSV](https://equitycapital.markets/filings.csv?cik=1689375)

---
Source page: https://equitycapital.markets/company/1689375 · Data: U.S. SEC EDGAR · CC BY 4.0